Alex N Bullock Selected Research

Alex N Bullock Research Topics

Disease

22	Neoplasms (Cancer) 01/2021 - 12/2005
14	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 06/2022 - 03/2011
7	Diffuse Intrinsic Pontine Glioma 01/2021 - 10/2014
7	Heterotopic Ossification (Ectopic Ossification) 01/2021 - 03/2011
4	Leukemia 10/2009 - 12/2005
3	Hypertension (High Blood Pressure) 01/2022 - 06/2014
2	Carcinogenesis 10/2022 - 09/2014
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 02/2014
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2018 - 11/2017
2	Hypoxia (Hypoxemia) 05/2007 - 07/2002
1	Medulloblastoma 10/2022
1	Ovarian Neoplasms (Ovarian Cancer) 06/2022
1	Bone Diseases (Bone Disease) 06/2022
1	Pseudohypoaldosteronism 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Soft Tissue Injuries (Soft Tissue Injury) 01/2021
1	Atherosclerosis 01/2021
1	Heart Diseases (Heart Disease) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Rare Diseases (Rare Disease) 12/2019
1	Pulmonary Arterial Hypertension 12/2019
1	Drug-Related Side Effects and Adverse Reactions 12/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Acute Lung Injury 01/2018
1	Inflammation (Inflammations) 11/2015
1	Parkinson Disease (Parkinson's Disease) 02/2014
1	Colorectal Neoplasms (Colorectal Cancer) 10/2013
1	Progeria (Hutchinson Gilford Syndrome) 03/2013
1	Laminopathies 03/2013
1	Premature Aging 03/2013
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2013
1	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2012
1	Disease Progression 03/2011
1	Lymphoma (Lymphomas) 10/2009
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2007
1	Hematologic Neoplasms (Hematological Malignancy) 07/2007

Drug/Important Bio-Agent (IBA)

16	Phosphotransferases (Kinase)IBA 06/2022 - 12/2007
6	dipinacoline glutamateIBA 01/2021 - 10/2014
6	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2021 - 10/2012
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2012
5	Bone Morphogenetic Protein ReceptorsIBA 01/2021 - 01/2013
4	UbiquitinIBA 10/2022 - 05/2007
4	Pharmaceutical PreparationsIBA 02/2021 - 02/2014
4	Type I Bone Morphogenetic Protein ReceptorsIBA 11/2019 - 06/2013
4	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019 - 10/2009
2	Ligases (Synthetase)IBA 10/2022 - 01/2019
2	saracatinibIBA 06/2022 - 01/2021
2	Tacrolimus Binding Protein 1A (FKBP12)IBA 01/2021 - 01/2018
2	Protein Kinases (Protein Kinase)IBA 01/2020 - 09/2010
2	CollagenIBA 01/2019 - 05/2007
2	Therapeutic UsesIBA 01/2016 - 11/2015
2	Serine (L-Serine)FDA Link 06/2013 - 03/2011
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2013 - 03/2011
2	proto-oncogene proteins pimIBA 07/2007 - 12/2005
2	CytokinesIBA 12/2005 - 12/2005
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2022
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Proline (L-Proline)FDA Link 01/2022
1	tacrolimus binding protein 1BIBA 01/2021
1	Discoidin Domain ReceptorsIBA 01/2021
1	Histones (Histone)IBA 01/2020
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2019
1	Proteolysis Targeting ChimeraIBA 12/2019
1	activin AIBA 11/2019
1	Discoidin Domain Receptor 1IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 11/2017
1	tetraethylpyrazine (TEP)IBA 11/2017
1	dabrafenibIBA 01/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2017
1	rebastinibIBA 01/2017
1	Interleukin-15 (Interleukin 15)IBA 01/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016
1	Imatinib Mesylate (Gleevec)FDA Link 06/2014
1	tyrosine receptor (receptor, tyrosine)IBA 06/2014
1	ponatinibIBA 06/2014
1	Protein Isoforms (Isoforms)IBA 06/2014
1	Kelch-Like ECH-Associated Protein 1IBA 02/2014
1	omipalisibIBA 10/2013
1	LigandsIBA 06/2013
1	Peptides (Polypeptides)IBA 03/2013
1	ZincIBA 03/2013
1	LaminsIBA 03/2013
1	Metalloproteases (Metalloproteinases)IBA 03/2013
1	LDN-212854IBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 11/2012
1	Casein Kinase II (Casein Kinase 2)IBA 09/2010
1	K00135IBA 07/2007
1	Hydroxyproline (4 Hydroxyproline)IBA 05/2007
1	Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA 12/2005
1	Mixed Function Oxygenases (Monooxygenases)IBA 07/2002
1	CobaltIBA 07/2002
1	Oxygen (Dioxygen)IBA 07/2002
1	AsparagineIBA 07/2002

Therapy/Procedure

5	Therapeutics 10/2022 - 09/2010
1	Immunotherapy 01/2016